Other

Property, Plant and Equipment, Gross, Period Increase (Decrease)

Vertex Pharmaceuticals Property, Plant and Equipment, Gross, Period Increase (Decrease) remained flat by 0.0% to -$26.88M in Q4 2025 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ1 2025
Last reportedQ4 2025Feb 13, 2026

How to read this metric

An increase suggests capital investment and expansion, while a decrease may indicate asset divestiture or aging infrastructure.

Detailed definition

Measures the net change in the gross carrying amount of property, plant, and equipment before accounting for accumulated...

Peer comparison

Standard metric for assessing capital intensity in manufacturing and biotech industries.

Metric ID: other_property_plant_and_equipment_gross_period_increase_68971b

Historical Data

1 years
 FY'25
Value-$107.50M

Frequently Asked Questions

What is Vertex Pharmaceuticals's property, plant and equipment, gross, period increase (decrease)?
Vertex Pharmaceuticals (VRTX) reported property, plant and equipment, gross, period increase (decrease) of -$26.88M in Q4 2025.
What does property, plant and equipment, gross, period increase (decrease) mean?
The net change in the total cost of physical assets owned by the company.